Exvading Tumors
Exvade, as the opposite of invade, relies on exploiting the invasive nature of malignant tumors, using bio-inspired cues to guide cancer migration to a ‘safe zone’ rather than blocking or killing the tumor.
Tumor Monorail
Breakthrough Designated technology by the FDA, Tumor Monorail is small catheter that sits in the vicinity of tumor using a proprietary polymeric nanofiber technology to guide intracortical brain tumor cells to an extracortical reservoir
Clinical Trial
First-in-man clinical trial of Tumor Monorail, for safety and functionality, has been started at The Preston Robert Tisch Brain Tumor Center at Duke University
